Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 127,12
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Condizione: As New. Unread book in perfect condition.
Condizione: New.
EUR 164,15
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. reprint edition. 200 pages. 9.25x6.10x0.46 inches. In Stock.
Condizione: New. pp. 184.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 163,58
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
EUR 104,15
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Resistance to Targeted Therapies in Breast Cancer | Jenifer R. Prosperi | Taschenbuch | Resistance to Targeted Anti-Cancer Therapeutics | xv | Englisch | 2018 | Springer | EAN 9783319888910 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
EUR 179,20
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: California Books, Miami, FL, U.S.A.
EUR 181,58
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 163,56
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
EUR 182,51
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Lingua: Inglese
Editore: Springer International Publishing, Springer International Publishing, 2018
ISBN 10: 3319888919 ISBN 13: 9783319888910
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 117,69
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling). We have also provided an overview of standard of care as an introduction into the importance of targeted therapy. It is our hope that this volume gives an insight into the landscape of breast cancer treatment, the challenges of targeted therapy, and a glimpse into the future of breast cancer therapy.
Lingua: Inglese
Editore: Springer Nature Switzerland, 2017
ISBN 10: 331970141X ISBN 13: 9783319701417
Da: Buchpark, Trebbin, Germania
EUR 77,45
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Hervorragend. Zustand: Hervorragend | Sprache: Englisch | Produktart: Bücher | We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling). We have also provided an overview of standard of care as an introduction into the importance of targeted therapy. It is our hope that this volume gives an insight into the landscape of breast cancer treatment, the challenges of targeted therapy, and a glimpse into the future of breast cancer therapy.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 180,74
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 196,41
Quantità: 15 disponibili
Aggiungi al carrelloCondizione: New.
Condizione: New.
Lingua: Inglese
Editore: Springer International Publishing, 2017
ISBN 10: 331970141X ISBN 13: 9783319701417
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 160,49
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling). We have also provided an overview of standard of care as an introduction into the importance of targeted therapy. It is our hope that this volume gives an insight into the landscape of breast cancer treatment, the challenges of targeted therapy, and a glimpse into the future of breast cancer therapy.
EUR 233,13
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 184 pages. 9.50x6.25x0.75 inches. In Stock.
Condizione: New.
Da: Norbert Kretschmann, Bad Aibling, Germania
EUR 73,80
Quantità: 1 disponibili
Aggiungi al carrelloGebundene Ausgabe. Condizione: Wie neu. 199 Seiten; 2017. Buchdeckel wie Innenteil tadellos - u n g e l e s e n - keine Risse, Knicke, Anmerkungen. ! KEIN Mängelexemplar! Versand aus München V13 Sprache: Deutsch Gewicht in Gramm: 471.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 94,25
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 126,26
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
Lingua: Inglese
Editore: Springer International Publishing Jun 2018, 2018
ISBN 10: 3319888919 ISBN 13: 9783319888910
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 117,69
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling). We have also provided an overview of standard of care as an introduction into the importance of targeted therapy. It is our hope that this volume gives an insight into the landscape of breast cancer treatment, the challenges of targeted therapy, and a glimpse into the future of breast cancer therapy. 200 pp. Englisch.
Lingua: Inglese
Editore: Springer International Publishing, 2018
ISBN 10: 3319888919 ISBN 13: 9783319888910
Da: moluna, Greven, Germania
EUR 98,54
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. This book will provide an in-depth description of resistance to targeted therapies in breast cancerThis book will discuss targeted therapies used to treat ER+ or Her2+ breast cancers (i.e. Tamoxifen or trastuzumab)This book will also discuss.
Lingua: Inglese
Editore: Springer, Palgrave Macmillan Jun 2018, 2018
ISBN 10: 3319888919 ISBN 13: 9783319888910
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 117,69
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling). We have also provided an overview of standard of care as an introduction into the importance of targeted therapy. It is our hope that this volume gives an insight into the landscape of breast cancer treatment, the challenges of targeted therapy, and a glimpse into the future of breast cancer therapy.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 200 pp. Englisch.
Lingua: Inglese
Editore: Springer International Publishing, 2017
ISBN 10: 331970141X ISBN 13: 9783319701417
Da: moluna, Greven, Germania
EUR 132,75
Quantità: Più di 20 disponibili
Aggiungi al carrelloGebunden. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. This book will provide an in-depth description of resistance to targeted therapies in breast cancerThis book will discuss targeted therapies used to treat ER+ or Her2+ breast cancers (i.e. Tamoxifen or trastuzumab)This book will also discuss.
Da: Majestic Books, Hounslow, Regno Unito
EUR 182,66
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand pp. 184.
Lingua: Inglese
Editore: Springer International Publishing Dez 2017, 2017
ISBN 10: 331970141X ISBN 13: 9783319701417
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 160,49
Quantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling). We have also provided an overview of standard of care as an introduction into the importance of targeted therapy. It is our hope that this volume gives an insight into the landscape of breast cancer treatment, the challenges of targeted therapy, and a glimpse into the future of breast cancer therapy. 200 pp. Englisch.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 183,15
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND pp. 184.
Lingua: Inglese
Editore: Springer, Palgrave Macmillan Dez 2017, 2017
ISBN 10: 331970141X ISBN 13: 9783319701417
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 160,49
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling). We have also provided an overview of standard of care as an introduction into the importance of targeted therapy. It is our hope that this volume gives an insight into the landscape of breast cancer treatment, the challenges of targeted therapy, and a glimpse into the future of breast cancer therapy.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 200 pp. Englisch.